Your browser doesn't support javascript.
loading
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Brentjens, Renier J; Rivière, Isabelle; Park, Jae H; Davila, Marco L; Wang, Xiuyan; Stefanski, Jolanta; Taylor, Clare; Yeh, Raymond; Bartido, Shirley; Borquez-Ojeda, Oriana; Olszewska, Malgorzata; Bernal, Yvette; Pegram, Hollie; Przybylowski, Mark; Hollyman, Daniel; Usachenko, Yelena; Pirraglia, Domenick; Hosey, James; Santos, Elmer; Halton, Elizabeth; Maslak, Peter; Scheinberg, David; Jurcic, Joseph; Heaney, Mark; Heller, Glenn; Frattini, Mark; Sadelain, Michel.
  • Brentjens RJ; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. brentjer@mskcc.org
Blood ; 118(18): 4817-28, 2011 Nov 03.
Article en En | MEDLINE | ID: mdl-21849486
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Leucemia de Células B / Inmunoterapia Adoptiva / Antígenos CD19 / Supervivencia de Injerto Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2011 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Leucemia de Células B / Inmunoterapia Adoptiva / Antígenos CD19 / Supervivencia de Injerto Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2011 Tipo del documento: Article